跳至主要内容
临床试验/NCT07511920
NCT07511920尚未招募不适用

A Real-World, Multicenter Cohort Study on the Natural History of Duchenne and Becker Muscular Dystrophy in Children From Western China

West China Second University Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2026年4月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
500
试验地点
1
主要终点
NorthStar Ambulatory Assessment (NSAA) score

研究概览

简要总结

This is a prospective, multicenter, longitudinal observational cohort study aimed at understanding the progression of Duchenne Muscular Dystrophy (DMD). The primary objective is to identify and integrate key biomarkers from multiple sources-including motor function assessments, body composition (muscle and fat distribution), clinical laboratory tests, and cardiopulmonary imaging-to delineate comprehensive disease trajectories. By analyzing how these factors change over time in a large cohort, the study seeks to develop a robust model that can identify patterns of disease progression. The ultimate goal is to generate evidence that may aid in forecasting individual patient outcomes and inform the future development of personalized rehabilitation and therapeutic strategies.

详细描述

Detailed Description

  1. Comprehensive Scientific Rationale and Knowledge Gap

Duchenne Muscular Dystrophy (DMD) is characterized by a highly heterogeneous disease trajectory that is not fully captured by single-domain assessments. While individual milestones of functional decline, such as loss of ambulation or decline in forced vital capacity, are well-established, the dynamic and complex interrelationships between skeletal muscle pathology, systemic fat metabolism, cardiopulmonary function, and real-world functional performance over time remain poorly quantified. This lack of a systems-level, integrated understanding of DMD progression fundamentally limits the ability of clinicians to prognosticate for individual patients, optimally time interventions, and proactively tailor rehabilitation and management plans.

Existing predictive models often rely on a limited set of functional or genetic parameters, failing to fully integrate the multi-systemic, physiological remodeling that occurs as the disease evolves. The central rationale for this study is that a more robust and clinically actionable understanding of progression can be achieved by synchronously capturing and integrating high-dimensional data across multiple physiological domains. Specifically, the detailed analysis of body composition-including the progressive atrophy of specific muscle groups, the patterns of ectopic fat infiltration within muscles and organs, and shifts in visceral adipose tissue distribution-is hypothesized to contain rich information reflective of the underlying molecular pathophysiology. We posit that the simultaneous longitudinal analysis of these compositional changes, in concert with traditional functional measures and advanced cardiopulmonary imaging, will reveal novel, synergistic biomarkers of disease progression that are not apparent when these domains are studied in isolation.

This study is designed to address a critical knowledge gap: the system-level mapping of how different organ systems deteriorate in relation to one another in DMD. The evidence base generated by this research is expected to be crucial for refining prognostic accuracy, informing the timely adjustment of rehabilitative strategies, and enabling sophisticated patient stratification for future clinical trials. 2. Overall Research Strategy and Multidimensional Data Integration Framework

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 18 Years(Child, Adult)
性别
Male
接受健康志愿者

入选标准

  • Male participants with genetically confirmed diagnosis of Duchenne Muscular Dystrophy (DMD) or Becker Muscular Dystrophy (BMD)
  • Age range: 1 to 18 years old (adjust to your actual age limit)
  • Ability to complete study assessments and follow-up visits
  • Participants or legal guardians provide written informed consent

排除标准

  • Participants with other neuromuscular disorders that may confound natural history data
  • Participation in another interventional clinical trial that could affect disease progression
  • Severe comorbidities that prevent completion of study assessments
  • Inability to provide informed consent or comply with study procedures

研究组 & 干预措施

DMD/BMD Cohort

Single cohort of children with Duchenne or Becker Muscular Dystrophy

干预措施: No interventions are applied; participants are followed for natural history observation only (Other)

结局指标

主要结局

NorthStar Ambulatory Assessment (NSAA) score

时间窗: Baseline and 24 months

The NorthStar Ambulatory Assessment (NSAA) is a validated clinical scale to measure motor function in ambulatory boys with Duchenne or Becker Muscular Dystrophy.

次要结局

未报告次要终点

研究者

发起方
West China Second University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yang Li

Xiaotang,Cai

West China Second University Hospital

研究点 (1)

Loading locations...

相似试验